UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Oxaliplatin Combined With Weekly Bolus Fluorouracil and Leucovorin As Surgical Adjuvant Chemotherapy for Stage II and III Colon Cancer: Results From NSABP C-07

Journal of clinical oncology, 2007-06, Vol.25 (16), p.2198-2204

2007

Volltextzugriff (PDF)

Review of high-dose intravenous vitamin C as an anticancer agent

Asia-Pacific journal of clinical oncology, 2014-03, Vol.10 (1), p.22-37

2014

Volltextzugriff (PDF)

MCF-7 breast cancer cells selected for tamoxifen resistance acquire new phenotypes differing in DNA content, phospho-HER2 and PAX2 expression, and rapamycin sensitivity

Cancer biology & therapy, 2010-05, Vol.9 (9), p.717-724

2010

Volltextzugriff (PDF)

Mapping a route to Indigenous engagement in cancer genomic research

The lancet oncology, 2019-06, Vol.20 (6), p.e327-e335

2019

Volltextzugriff (PDF)

Phase II Study of the Dual EGFR/HER3 Inhibitor Duligotuzumab (MEHD7945A) versus Cetuximab in Combination with FOLFIRI in Second-Line RAS Wild-Type Metastatic Colorectal Cancer

Clinical cancer research, 2018-05, Vol.24 (10), p.2276-2284

2018

Volltextzugriff (PDF)

A phase I vaccination study with dendritic cells loaded with NY-ESO-1 and α-galactosylceramide: induction of polyfunctional T cells in high-risk melanoma patients

Cancer Immunology, Immunotherapy, 2018-02, Vol.67 (2), p.285-298

2018

Volltextzugriff (PDF)

A simple ex vivo bioassay for 5-FU transport into healthy buccal mucosal cells

Cancer chemotherapy and pharmacology, 2019-10, Vol.84 (4), p.739-748

2019

Volltextzugriff (PDF)

Dendritic cell vaccination combined with temozolomide retreatment: results of a phase I trial in patients with recurrent glioblastoma multiforme

Journal of neuro-oncology, 2015-01, Vol.121 (2), p.319-329

2015

Volltextzugriff (PDF)

Summary scores captured changes in subjects' QoL as measured by the multiple scales of the EORTC QLQ-C30

Journal of clinical epidemiology, 2015-08, Vol.68 (8), p.895-902

2015

Volltextzugriff (PDF)

Everolimus and Zoledronic Acid in Patients With Renal Cell Carcinoma With Bone Metastases: A Randomized First-Line Phase II Trial

Clinical genitourinary cancer, 2015-02, Vol.13 (1), p.50-58

2015

Volltextzugriff (PDF)

Gene expression profiling of breast tumours from New Zealand patients

New Zealand medical journal, 2017-10, Vol.130 (1464), p.40-56

Muthukaruppan, Anita

2017

Volltextzugriff (PDF)

Multimodal assessment of oestrogen receptor mRNA profiles to quantify oestrogen pathway activity in breast tumours

Clinical breast cancer, 2017-04, Vol.17 (2), p.139-153

2017

Volltextzugriff (PDF)

Methods of a national colorectal cancer cohort study : the PIPER Project

New Zealand medical journal, 2016-08, Vol.129 (1440), p.25-36

Firth, Melissa J

2016

Volltextzugriff (PDF)

Dose-intense capecitabine, oxaliplatin and bevacizumab as first line treatment for metastatic, unresectable colorectal cancer: a multi-centre phase II study

BMC cancer, 2014-10, Vol.14 (1), p.737, Article 737

2014

Volltextzugriff (PDF)

Dietary patterns and information needs of colorectal cancer patients post-surgery in Auckland

New Zealand medical journal, 2012-06, Vol.125 (1356), p.38-46

2012

Volltextzugriff (PDF)

Evidence-based update of chemotherapy options for metastatic colorectal cancer

ANZ journal of surgery, 2004-09, Vol.74 (9), p.781-787

2004

Volltextzugriff (PDF)

Final analysis of a randomized placebo-controlled double-blind phase II trial of perioperative cimetidine (CIM) in early colorectal cancer (CRC)

Journal of clinical oncology, 2018-05, Vol.36 (15_suppl), p.e15678-e15678

2018

Volltextzugriff (PDF)

Investigating strategies to improve clinical trial opportunities in oncology in New Zealand (INSIGHT)

Journal of clinical oncology, 2018-05, Vol.36 (15_suppl), p.e18851-e18851

2018

Volltextzugriff (PDF)

Abstract 5548: Genotype-phenotype discordance of the hepatic drug metabolism enzyme CYP2C19 in gastrointestinal cancer patients

Cancer research (Chicago, Ill.), 2014-10, Vol.74 (19_Supplement), p.5548-5548

2014

Volltextzugriff (PDF)

Cisplatin, epirubicin, capecitabine, and gemcitabine (PEXG) as first-line treatment in metastatic or unresectable pancreatic cancer: Active and well tolerated?

Journal of clinical oncology, 2014-05, Vol.32 (15_suppl), p.e15217-e15217

2014

Volltextzugriff (PDF)

SIRFLOX study: Novel approach to define depth of response (DpR) within a volumetric model in patients with metastatic colorectal cancer (mCRC)

Journal of clinical oncology, 2016-05, Vol.34 (15_suppl), p.3542-3542

2016

Volltextzugriff (PDF)

A randomized, placebo-controlled, double-blind phase 2 trial of peri-operative cimetidine (CIM) in early colorectal cancer (CRC)

Journal of clinical oncology, 2015-05, Vol.33 (15_suppl), p.e14598-e14598

2015

Volltextzugriff (PDF)

A randomized, placebo-controlled, double-blind phase II trial of peri-operative cimetidine in early colorectal cancer

Journal of clinical oncology, 2014-01, Vol.32 (3_suppl), p.509-509

2014

Volltextzugriff (PDF)

1 – 25 von 235

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(217)
Mit Volltextzugriff
(188)

Publikationsform

Sprache

Englisch
(233)
Französisch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Oxaliplatin Combined With Weekly Bolus Fluorouracil and Leucovorin As Surgical Adjuvant Chemotherapy for Stage II and III Colon Cancer: Results From NSABP C-07

Review of high-dose intravenous vitamin C as an anticancer agent

SIRFLOX: Randomized Phase III Trial Comparing First-Line mFOLFOX6 (Plus or Minus Bevacizumab) Versus mFOLFOX6 (Plus or Minus Bevacizumab) Plus Selective Internal Radiation Therapy in Patients With Metastatic Colorectal Cancer

MCF-7 breast cancer cells selected for tamoxifen resistance acquire new phenotypes differing in DNA content, phospho-HER2 and PAX2 expression, and rapamycin sensitivity

Mapping a route to Indigenous engagement in cancer genomic research

Phase II Study of the Dual EGFR/HER3 Inhibitor Duligotuzumab (MEHD7945A) versus Cetuximab in Combination with FOLFIRI in Second-Line RAS Wild-Type Metastatic Colorectal Cancer

A phase I vaccination study with dendritic cells loaded with NY-ESO-1 and α-galactosylceramide: induction of polyfunctional T cells in high-risk melanoma patients

A randomised controlled trial of long NY-ESO-1 peptide-pulsed autologous dendritic cells with or without alpha-galactosylceramide in high-risk melanoma

A simple ex vivo bioassay for 5-FU transport into healthy buccal mucosal cells

Dendritic cell vaccination combined with temozolomide retreatment: results of a phase I trial in patients with recurrent glioblastoma multiforme

Summary scores captured changes in subjects' QoL as measured by the multiple scales of the EORTC QLQ-C30

Everolimus and Zoledronic Acid in Patients With Renal Cell Carcinoma With Bone Metastases: A Randomized First-Line Phase II Trial

Gene expression profiling of breast tumours from New Zealand patients

Multimodal assessment of oestrogen receptor mRNA profiles to quantify oestrogen pathway activity in breast tumours

Methods of a national colorectal cancer cohort study : the PIPER Project

Dose-intense capecitabine, oxaliplatin and bevacizumab as first line treatment for metastatic, unresectable colorectal cancer: a multi-centre phase II study

Dietary patterns and information needs of colorectal cancer patients post-surgery in Auckland

Evidence-based update of chemotherapy options for metastatic colorectal cancer

Final analysis of a randomized placebo-controlled double-blind phase II trial of perioperative cimetidine (CIM) in early colorectal cancer (CRC)

Investigating strategies to improve clinical trial opportunities in oncology in New Zealand (INSIGHT)

Abstract 5548: Genotype-phenotype discordance of the hepatic drug metabolism enzyme CYP2C19 in gastrointestinal cancer patients

Cisplatin, epirubicin, capecitabine, and gemcitabine (PEXG) as first-line treatment in metastatic or unresectable pancreatic cancer: Active and well tolerated?

SIRFLOX study: Novel approach to define depth of response (DpR) within a volumetric model in patients with metastatic colorectal cancer (mCRC)

A randomized, placebo-controlled, double-blind phase 2 trial of peri-operative cimetidine (CIM) in early colorectal cancer (CRC)

A randomized, placebo-controlled, double-blind phase II trial of peri-operative cimetidine in early colorectal cancer

Suchergebnisse filtern